Literature DB >> 17359695

[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].

Rong-ping Guo1, Chong Zhong, Ming Shi, Chang-qing Zhang, Wei Wei, Ya-qi Zhang, Jin-qing Li.   

Abstract

OBJECTIVE: To investigate the expression and clinical significance of some apoptosis and angiogenesis factors in hepatocellular carcinoma (HCC).
METHODS: The expression of p53, Survivin, matrix metalloproteinases (MMP)-2, MMP-9 and vascular endothelial growth factor (VEGF) in 90 specimens of HCC was detected by immunohistochemistry. Correlations of the factors to the recurrence of HCC after hepatectomy were analyzed.
RESULTS: The positive rate of p53, Survivin, MMP-2, MMP-9 and VEGF in HCC tissue was 33.3%, 51.1%, 60.0%, 37.8% and 76.7%, respectively. Of the 5 factors, positive correlation only occurred between the expression of MMP-2 and VEGF, MMP-9 and VEGF. The expression of MMP-2, MMP-9 and VEGF was correlated to the recurrence of HCC. The 1-, 2-, and 3-year tumor-free survival rates were significantly higher in MMP-2 (-) group than in MMP-2 (+) group, and the same results were found with MMP-9 and VEGF. Multivariate analysis revealed that macroscopically disseminated nodules, tumor micrometastasis, serum alpha fetal protein (AFP) level, the expression of MMP-9 and VEGF were independent recurrence risk factors in HCC.
CONCLUSIONS: Neither p53 nor Survivin is correlated to the recurrence of HCC; MMPs and VEGF are correlated to the recurrence, and can be used to estimate the risk of postoperative recurrence of HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17359695

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres.

Authors:  Xi Li; S Ali Montazeri; Ricardo Paz-Fumagalli; Carlos A Padula; Weiping Wang; Kabir Mody; Lewis R Roberts; Tushar Patel; Sunil Krishnan; Beau Toskich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-13       Impact factor: 9.236

2.  Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?

Authors:  Fang-Zhen Shen; Jing Wang; Jun Liang; Kun Mu; Ji-Yuan Hou; Yan-Tao Wang
Journal:  Int J Exp Pathol       Date:  2010-02       Impact factor: 1.925

3.  Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.

Authors:  Jin Long Liu; Xue Jun Zhang; Zhao Zhang; An Hong Zhang; Wei Wang; Jia Hong Dong
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.